Sincerity Applied Materials Holdings Corp.
SINCAbout the company
Sincerity Applied Materials Holdings Corp. provides advanced nano-engineered glass materials and water treatment chemicals in Australia and internationally. The company offers chemicals and coatings, water-soluble packed household chemicals, and cellulose films, as well as product engineering solutions.
Investment snapshot
Positive
1
BUY / PASS
Neutral / negative
1 / 14
NEUTRAL / FAIL
Median fair value
$0.15
-85.0% vs price
Models with upside
0 / 17
Positive margin of safety
Key risk
No clean pass — all 16 investors flag at least one profitability criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | FAIL · Rank #2452 (Top 79.2%) | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | -566.7% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Market data at 2026-11-01 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Market data at 2026-11-01 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Qualitative assessment Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 Latest source filing: 2022-03-30 Score computed: 2026-11-14 | Annual history · FY 2021 · Price history 2025-01-01–2026-11-01 Latest source filing: 2022-03-30 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Profitability0% pass✓ 4✗ 31▾
No clean pass — all 16 investors flag at least one profitability criterion
Positive EPS (10 years)1/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)3/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)2548.0%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-138.6% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$-0.1M✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-120.6%✗Lynch> 15%EBIT / Enterprise Value-0.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-0.1%, ROC=-42557.6%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets-8.60%✗PiotroskiROA > 0ROA Change YoY10.90% -> -8.60% (delta: -19.50%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=5.00%, ROA=-8.60%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY25.4% -> 66.1%✓PiotroskiImproved YoYPre-Tax Income / Revenue-113.5%✗Dreman>= 8%Net Income / Shareholders' Equity-120.6%✗Dreman> 12%Margin of SafetyP/B=1446.9x✗PabraiP/B < 1.5 or P/E < 15Return on Equity-19.0% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency3/10 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-138.6%✗Ackman>= 15%Net Income / Shareholders Equity-120.6%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-4.8% (2019) -> -138.6% (2021)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 15.1% -> 66.1%, operating margin -4.8% -> -138.6%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-0.08%; #3220/6340 (top 50.8%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+5.83%; #3066/3702 (top 82.8%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity-120.57%; #4679/5226 (top 89.5%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-5.5852; #5642/5884 (top 95.9%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years1/9 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation0% pass✗ 28▾
All 13 investors flag SINC's valuation
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio1446.9x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-0.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-0.1%, ROC=-42557.6%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)2062.9x✗Dreman< 8xPrice / Book Value per Share1446.9x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessOE Yield=-0.1%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=0.0%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=1446.9x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share2062.9x✗Ackman<= 25Price vs. Trailing Low370% of trailing low ($0.27)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-0.08%; #3220/6340 (top 50.8%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.0006; #5244/6449 (top 81.3%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1446.87x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.0008; #5030/5247 (top 95.9%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+0.04%; #2528/4519 (top 55.9%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-41.18%; #4847/6202 (top 78.2%)✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 1✗ 12▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency3/10 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-56.5%✗Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 15.1% -> 66.1%, operating margin -4.8% -> -138.6%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR-41.4%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency0% pass✗ 11▾
All 8 investors flag SINC's efficiency
Current Ratio0.78✗Graham>= 2.0ROIC (3-5 yr avg)-180.2%✗Buffett> 10%ROIC - WACC-190.2%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)-42557.6%✗Greenblatt> 25%Current Ratio Change YoY0.94 -> 0.78✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.61x -> 0.09x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities0.78✗Dreman> 1.5Return on Invested Capital-68.9%✗Munger> 15%ROIC (high and growing)FY2019: ROIC=-16.6%; FY2020: ROIC=32.5%; FY2021: ROIC=-68.9%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)1/4 years above 12% (latest -68.9%)✗SleepROIC > 12% in a majority of years - Verdicts6% pass✓ 1✗ 15▾
Split decision: 14 FAIL · 1 PASS · 1 NEUTRAL
Overall verdict✗GrahamFAIL (0/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)✗GreenblattRank #2452✓PiotroskiPASS (F-Score 5)✗DremanFAIL (0/11)✗MungerFAIL (0/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (2/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #2360/2370 (Top 99.6%))✗NeffFAIL (1/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow20% pass✓ 3✗ 9▾
8 of 10 flag SINC's cash flow — Buffett, Lynch, Dreman +5 more
Free Cash Flow Proxy$-0.1M✗BuffettPositive and growingFCF Positive and Growing$0.0M✗LynchPositive and growingOperating Cash Flow$0.0M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=5.00%, ROA=-8.60%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)2062.9x✗Dreman< 8xP/E or FCF YieldFCF Yield=0.0%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive3/10 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap0.0%✗Ackman>= 4%Price / FCF per Share2062.9x✗Ackman<= 25Positive Operating Cash Flow frequency3/10 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$0.0M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+0.04%; #2528/4519 (top 55.9%)✗OshaughnessyTop 10% of eligible cross-section - Debt & Leverage25% pass✓ 5✗ 10▾
9 of 12 flag SINC's debt & leverage — Graham, Buffett, Lynch +6 more
Total Debt / Shareholders' Equity0.97✗Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xLT Debt vs Net Current AssetsLT Debt $0.0M vs NCA $-0.1M✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.97, IC: -14.6x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.97✗Lynch< 0.33Cash - Long-term Debt$0.0M✓LynchPositive preferredLT Debt / Total Assets Change7.68% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities0.78✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Debt Levels0.97✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=-14.6x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.97✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.9663; #3189/4210 (top 75.7%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2021. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2021
Retired 0.0% of shares last year, 0.0% over two.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2021Sources
| FY 2020Sources
| FY 2019Sources
| FY 2018Sources
| FY 2017Sources
|
|---|---|---|---|---|---|
| Market Cap | $80.8Mcurrent | $9.3Test. | $7.4Test. | $21657.2Test. | $9430.3Test. |
| Revenue | $63.0K↓87% | $482.6K↓29% | $677.5K↓57% | $1.6M↓28% | $2.2M |
| Operating Income | -$87.2K↓218% | $74.2K↑329% | -$32.4K↑91% | -$361.5K↑86% | -$2.6M |
| Net Income | -$61.3K↓172% | $85.6K↑832% | -$11.7K↓102% | $761.8K↑119% | -$4.0M |
| EPS (Diluted) | -- | $0.00 | $0.00↓100% | $0.02↑125% | $-0.08 |
| Gross Margin | 66.1%↑160% | 25.4%↑68% | 15.1%↑176% | 5.5%↓41% | 9.3% |
| Operating Margin | -138.6%↓1001% | 15.4%↑422% | -4.8%↑79% | -23.2%↑81% | -120.4% |
| ROE | -120.6%↓236% | 88.9%↑451% | -25.3%↓100% | 13450.0%↑6947% | 190.9% |
| Total Debt | $49.1K↓42% | $84.4K↓22% | $108.3K↓18% | $131.3K↑82% | $72.3K |
| Shareholders' Equity | $50.9K↓47% | $96.3K↑109% | $46.1K↑715% | $5.7K↑100% | -$2.1M |
| Current Ratio | 0.78↓16% | 0.94↑16% | 0.81↑18% | 0.68↑764% | 0.08 |
| Debt / Equity | 0.97↑10% | 0.88↓63% | 2.35↓90% | 23.18↑67154% | -0.03 |
| Operating Cash Flow | $35.7K↓85% | $236.7K↑146% | $96.2K↑115% | -$636.4K↓929% | -$61.9K |
| Free Cash Flow | $35.7K↓85% | $236.7K↑146% | $96.2K↑115% | -$636.4K↓849% | -$67.1K |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Chemicals
SINC vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EIDP, Inc.CTA-PB | $46.8B | $54.21 | — | — | — | — | — | — | 2/9 | 5/9 | 2/7 | 0/3 | F-Score 1 | 4/11 |
| CF Industries Holdings, Inc.CF | $18.3B | $125.09 | $7.1B | $1.8B | 37.2% | 0.66 | 32.5% | 3.37 | 3/9 | 4/9 | 5/7 | 3/3 | F-Score 8 | 8/11 |
| RPM INTERNATIONAL INC/DE/RPM | $13.2B | $103.73 | $7.9B | $661.4M | 20.0% | 0.77 | — | 1.68 | 3/9 | 2/9 | 3/7 | 1/3 | F-Score 6 | 7/11 |
| Element Solutions IncESI | $8.0B | $33.08 | $2.6B | $190.8M | 7.1% | 0.61 | 13.4% | 3.68 | 2/9 | 2/9 | 1/7 | 1/3 | F-Score 5 | 6/11 |
| NEWMARKET CORPNEU | $6.5B | $709.19 | $2.7B | $418.7M | 23.5% | 0.50 | 20.0% | 2.53 | 4/9 | 6/9 | 2/7 | 1/3 | F-Score 5 | 5/11 |
| HEXCEL CORP /DE/HXL | $6.0B | $79.46 | $1.9B | $109.4M | 8.7% | 0.79 | 9.1% | 2.26 | 2/9 | 2/9 | 3/7 | 0/3 | F-Score 6 | 4/11 |
| ICL Group Ltd.ICL | $5.8B | $4.52 | $7.2B | $226.0M | 3.8% | 0.46 | 8.1% | 1.33 | 5/9 | 4/9 | 2/7 | 0/3 | F-Score 4 | 5/11 |
| BALCHEM CORPBCPC | $5.5B | $173.14 | $1.0B | $154.8M | 12.3% | 0.13 | 20.2% | 2.07 | 2/9 | 4/9 | 2/7 | 1/3 | F-Score 9 | 5/11 |